| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.52e-05 | 187 | 57 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 4.98e-05 | 231 | 57 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | TPR domain binding | 2.22e-04 | 8 | 57 | 2 | GO:0030911 | |
| GeneOntologyMolecularFunction | RNA polymerase I core promoter sequence-specific DNA binding | 4.33e-04 | 11 | 57 | 2 | GO:0001164 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 4.67e-04 | 53 | 57 | 3 | GO:0030331 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 4.89e-04 | 229 | 57 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 5.76e-04 | 507 | 57 | 7 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 5.76e-04 | 507 | 57 | 7 | GO:0030695 | |
| GeneOntologyMolecularFunction | RNA polymerase I transcription regulatory region sequence-specific DNA binding | 6.12e-04 | 13 | 57 | 2 | GO:0001163 | |
| GeneOntologyMolecularFunction | cGMP binding | 9.36e-04 | 16 | 57 | 2 | GO:0030553 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.05e-03 | 562 | 57 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.18e-03 | 417 | 57 | 6 | GO:0061629 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 1.47e-03 | 20 | 57 | 2 | GO:0061608 | |
| GeneOntologyMolecularFunction | DNA polymerase binding | 1.95e-03 | 23 | 57 | 2 | GO:0070182 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.95e-03 | 23 | 57 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 2.30e-03 | 25 | 57 | 2 | GO:0031683 | |
| GeneOntologyMolecularFunction | cAMP binding | 2.30e-03 | 25 | 57 | 2 | GO:0030552 | |
| GeneOntologyMolecularFunction | dopamine receptor binding | 2.49e-03 | 26 | 57 | 2 | GO:0050780 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 2.68e-03 | 27 | 57 | 2 | GO:0008139 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 4.31e-06 | 86 | 58 | 5 | GO:0007193 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOR2 TCF7 UBTFL6 RBBP6 GNA13 DAB2 SMARCA4 APOB ATM ACVR1C ARID1A LEF1 | 6.61e-06 | 906 | 58 | 12 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | NCOR2 TCF7 UBTFL6 RBBP6 GNA13 DAB2 SMARCA4 APOB ATM ACVR1C ARID1A LEF1 | 8.53e-06 | 929 | 58 | 12 | GO:0009792 |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 1.27e-05 | 51 | 58 | 4 | GO:0030521 | |
| GeneOntologyBiologicalProcess | negative regulation of androgen receptor signaling pathway | 1.40e-05 | 17 | 58 | 3 | GO:0060766 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.50e-05 | 286 | 58 | 7 | GO:0007188 | |
| GeneOntologyBiologicalProcess | embryo development | NCOR2 TCF7 UBTFL6 ACTR5 RBBP6 GNA13 DAB2 SMARCA4 APOB ATM ACVR1C ARID1A LEF1 DISP1 | 3.30e-05 | 1437 | 58 | 14 | GO:0009790 |
| GeneOntologyBiologicalProcess | V(D)J recombination | 3.59e-05 | 23 | 58 | 3 | GO:0033151 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 3.98e-05 | 596 | 58 | 9 | GO:0001701 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 4.01e-05 | 136 | 58 | 5 | GO:0030518 | |
| GeneOntologyBiologicalProcess | epithelium development | ENAM NCOR2 PDE2A TCF7 RBBP6 GNA13 DAB2 PKHD1 SMARCA4 RAB1B ATM RAPGEF2 ARID1A LEF1 | 4.21e-05 | 1469 | 58 | 14 | GO:0060429 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 4.47e-05 | 605 | 58 | 9 | GO:0071407 | |
| GeneOntologyBiologicalProcess | blood vessel development | SCN11A PDE2A NPR3 GNA13 SMARCA4 APOB RAPGEF2 ARID1A FASLG LEF1 VAV2 | 4.76e-05 | 929 | 58 | 11 | GO:0001568 |
| GeneOntologyBiologicalProcess | vasculature development | SCN11A PDE2A NPR3 GNA13 SMARCA4 APOB RAPGEF2 ARID1A FASLG LEF1 VAV2 | 6.96e-05 | 969 | 58 | 11 | GO:0001944 |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 7.47e-05 | 155 | 58 | 5 | GO:0043401 | |
| GeneOntologyBiologicalProcess | somatic recombination of T cell receptor gene segments | 7.73e-05 | 5 | 58 | 2 | GO:0002681 | |
| GeneOntologyBiologicalProcess | T cell receptor V(D)J recombination | 7.73e-05 | 5 | 58 | 2 | GO:0033153 | |
| GeneOntologyBiologicalProcess | somatic diversification of T cell receptor genes | 7.73e-05 | 5 | 58 | 2 | GO:0002568 | |
| GeneOntologyBiologicalProcess | cellular response to abiotic stimulus | 7.86e-05 | 371 | 58 | 7 | GO:0071214 | |
| GeneOntologyBiologicalProcess | cellular response to environmental stimulus | 7.86e-05 | 371 | 58 | 7 | GO:0104004 | |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 8.97e-05 | 31 | 58 | 3 | GO:0060765 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 1.05e-04 | 87 | 58 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | blastocyst growth | 1.08e-04 | 33 | 58 | 3 | GO:0001832 | |
| GeneOntologyBiologicalProcess | tube development | KIF18A NCOR2 NPR3 TCF7 GNA13 PKHD1 SMARCA4 APOB RAPGEF2 ARID1A FASLG LEF1 VAV2 | 1.11e-04 | 1402 | 58 | 13 | GO:0035295 |
| GeneOntologyBiologicalProcess | telomerase holoenzyme complex assembly | 1.16e-04 | 6 | 58 | 2 | GO:1905323 | |
| GeneOntologyBiologicalProcess | circulatory system development | NCOR2 SCN11A PDE2A NPR3 GNA13 SMARCA4 APOB ATM RAPGEF2 ARID1A FASLG LEF1 VAV2 | 1.47e-04 | 1442 | 58 | 13 | GO:0072359 |
| GeneOntologyBiologicalProcess | cellular response to cGMP | 1.62e-04 | 7 | 58 | 2 | GO:0071321 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-4 | 1.66e-04 | 38 | 58 | 3 | GO:0071353 | |
| GeneOntologyBiologicalProcess | negative regulation of intracellular steroid hormone receptor signaling pathway | 1.94e-04 | 40 | 58 | 3 | GO:0033144 | |
| GeneOntologyBiologicalProcess | response to interleukin-4 | 2.08e-04 | 41 | 58 | 3 | GO:0070670 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 2.58e-04 | 202 | 58 | 5 | GO:0141193 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | NPR3 TCF7 GNA13 PKHD1 SMARCA4 APOB RAPGEF2 ARID1A FASLG LEF1 VAV2 | 2.59e-04 | 1125 | 58 | 11 | GO:0035239 |
| GeneOntologyBiologicalProcess | response to cGMP | 2.76e-04 | 9 | 58 | 2 | GO:0070305 | |
| GeneOntologyBiologicalProcess | RNA polymerase I preinitiation complex assembly | 4.21e-04 | 11 | 58 | 2 | GO:0001188 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | NCOR2 PDE2A TCF7 DAB2 SMARCA4 CDY2A ARID1A FASLG LEF1 ARID5A NKRF CDY1 | 4.35e-04 | 1399 | 58 | 12 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | NCOR2 PDE2A TCF7 DAB2 SMARCA4 CDY2A ARID1A FASLG LEF1 ARID5A NKRF CDY1 | 4.76e-04 | 1413 | 58 | 12 | GO:1902679 |
| GeneOntologyBiologicalProcess | artery development | 5.35e-04 | 133 | 58 | 4 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 5.57e-04 | 239 | 58 | 5 | GO:0071383 | |
| GeneOntologyBiologicalProcess | establishment of endothelial barrier | 5.83e-04 | 58 | 58 | 3 | GO:0061028 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 6.11e-04 | 244 | 58 | 5 | GO:0009755 | |
| GeneOntologyBiologicalProcess | nuclear transport | 6.60e-04 | 378 | 58 | 6 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 6.60e-04 | 378 | 58 | 6 | GO:0006913 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 6.74e-04 | 870 | 58 | 9 | GO:0030855 | |
| GeneOntologyBiologicalProcess | intracellular transport | KPNA5 DENND10 WASHC4 AP3B2 DAB2 NXF2 KPNA6 RAB1B TRAPPC8 ECT2 TMEM87A HSP90AB1 | 7.93e-04 | 1496 | 58 | 12 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell differentiation | 7.97e-04 | 15 | 58 | 2 | GO:0045586 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 8.14e-04 | 65 | 58 | 3 | GO:0045815 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | 8.19e-04 | 546 | 58 | 7 | GO:0051656 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 9.29e-04 | 68 | 58 | 3 | GO:0141137 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 9.48e-04 | 269 | 58 | 5 | GO:0002064 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell activation | 1.03e-03 | 17 | 58 | 2 | GO:0046643 | |
| GeneOntologyBiologicalProcess | establishment of endothelial intestinal barrier | 1.03e-03 | 17 | 58 | 2 | GO:0090557 | |
| GeneOntologyBiologicalProcess | positive regulation by host of viral transcription | 1.03e-03 | 17 | 58 | 2 | GO:0043923 | |
| GeneOntologyBiologicalProcess | lipoprotein catabolic process | 1.03e-03 | 17 | 58 | 2 | GO:0042159 | |
| GeneOntologyBiologicalProcess | response to lipid | WBP2 KIF18A NCOR2 SCN11A DAB2 SMARCA4 ATM ARID1A FASLG ARID5A | 1.08e-03 | 1126 | 58 | 10 | GO:0033993 |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 1.08e-03 | 416 | 58 | 6 | GO:0030522 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | 1.11e-03 | 748 | 58 | 8 | GO:0071396 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase I promoter | 1.16e-03 | 18 | 58 | 2 | GO:0006361 | |
| GeneOntologyCellularComponent | bBAF complex | 3.36e-04 | 10 | 58 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | NLS-dependent protein nuclear import complex | 3.36e-04 | 10 | 58 | 2 | GO:0042564 | |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 4.91e-04 | 12 | 58 | 2 | GO:0031074 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 5.79e-04 | 13 | 58 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | npBAF complex | 6.74e-04 | 14 | 58 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 7.42e-04 | 147 | 58 | 4 | GO:0030665 | |
| GeneOntologyCellularComponent | nBAF complex | 8.86e-04 | 16 | 58 | 2 | GO:0071565 | |
| Domain | CTNNB1-bd_N | 5.66e-05 | 4 | 58 | 2 | IPR013558 | |
| Domain | CTNNB1_binding | 5.66e-05 | 4 | 58 | 2 | PF08347 | |
| Domain | TCF/LEF | 5.66e-05 | 4 | 58 | 2 | IPR024940 | |
| Domain | Arm_3 | 1.97e-04 | 7 | 58 | 2 | PF16186 | |
| Domain | Importing_su_alpha | 1.97e-04 | 7 | 58 | 2 | IPR024931 | |
| Domain | Arm_3 | 1.97e-04 | 7 | 58 | 2 | IPR032413 | |
| Domain | IBB | 1.97e-04 | 7 | 58 | 2 | PF01749 | |
| Domain | IBB | 2.62e-04 | 8 | 58 | 2 | PS51214 | |
| Domain | Importin-a_IBB | 3.36e-04 | 9 | 58 | 2 | IPR002652 | |
| Domain | Chromo_dom_subgr | 4.20e-04 | 10 | 58 | 2 | IPR017984 | |
| Domain | HMG_box | 5.96e-04 | 53 | 58 | 3 | PF00505 | |
| Domain | ARM-type_fold | 6.26e-04 | 339 | 58 | 6 | IPR016024 | |
| Domain | HMG_BOX_2 | 6.30e-04 | 54 | 58 | 3 | PS50118 | |
| Domain | HMG | 6.30e-04 | 54 | 58 | 3 | SM00398 | |
| Domain | - | 9.70e-04 | 15 | 58 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 9.70e-04 | 15 | 58 | 2 | SM00501 | |
| Domain | ARID_dom | 9.70e-04 | 15 | 58 | 2 | IPR001606 | |
| Domain | ARID | 9.70e-04 | 15 | 58 | 2 | PS51011 | |
| Domain | ARID | 9.70e-04 | 15 | 58 | 2 | PF01388 | |
| Domain | HMG_box_dom | 1.08e-03 | 65 | 58 | 3 | IPR009071 | |
| Domain | Crotonase_core_superfam | 1.25e-03 | 17 | 58 | 2 | IPR001753 | |
| Domain | ECH_1 | 1.25e-03 | 17 | 58 | 2 | PF00378 | |
| Domain | Chromo | 2.94e-03 | 26 | 58 | 2 | PF00385 | |
| Domain | CHROMO_1 | 3.40e-03 | 28 | 58 | 2 | PS00598 | |
| Domain | CHROMO_2 | 3.40e-03 | 28 | 58 | 2 | PS50013 | |
| Domain | Catenin_binding_dom | 3.65e-03 | 29 | 58 | 2 | IPR027397 | |
| Domain | - | 3.65e-03 | 29 | 58 | 2 | 4.10.900.10 | |
| Domain | Arm | 4.16e-03 | 31 | 58 | 2 | PF00514 | |
| Domain | Chromodomain-like | 4.43e-03 | 32 | 58 | 2 | IPR016197 | |
| Domain | Chromo/shadow_dom | 4.70e-03 | 33 | 58 | 2 | IPR000953 | |
| Domain | CHROMO | 4.70e-03 | 33 | 58 | 2 | SM00298 | |
| Domain | - | 4.99e-03 | 222 | 58 | 4 | 1.25.10.10 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 7.51e-05 | 26 | 45 | 3 | MM14793 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 1.48e-04 | 6 | 45 | 2 | MM15542 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY | 1.48e-04 | 6 | 45 | 2 | M47736 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY | 2.07e-04 | 7 | 45 | 2 | M47465 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 2.33e-04 | 95 | 45 | 4 | M48268 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 2.76e-04 | 8 | 45 | 2 | MM17229 | |
| Pathway | REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS | 2.76e-04 | 8 | 45 | 2 | M27359 | |
| Pathway | KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY | 2.76e-04 | 8 | 45 | 2 | M47413 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 2.76e-04 | 8 | 45 | 2 | M27821 | |
| Pathway | KEGG_MELANOGENESIS | 2.95e-04 | 101 | 45 | 4 | M7761 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 3.20e-04 | 42 | 45 | 3 | M48237 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 4.09e-04 | 110 | 45 | 4 | M39492 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 4.41e-04 | 10 | 45 | 2 | MM1532 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY | 4.41e-04 | 10 | 45 | 2 | M47486 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 4.41e-04 | 10 | 45 | 2 | MM15156 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 6.02e-04 | 52 | 45 | 3 | MM14743 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY | 6.44e-04 | 12 | 45 | 2 | M47410 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 6.44e-04 | 12 | 45 | 2 | M22006 | |
| Pathway | WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA | 7.49e-04 | 56 | 45 | 3 | M39413 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 8.72e-04 | 59 | 45 | 3 | M11215 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 8.85e-04 | 14 | 45 | 2 | M27402 | |
| Pathway | REACTOME_FORMATION_OF_AXIAL_MESODERM | 8.85e-04 | 14 | 45 | 2 | M46441 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 9.34e-04 | 137 | 45 | 4 | M48232 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.01e-03 | 62 | 45 | 3 | M27321 | |
| Pathway | PID_THROMBIN_PAR4_PATHWAY | 1.02e-03 | 15 | 45 | 2 | M138 | |
| Pathway | WP_CANCER_PATHWAYS | 1.03e-03 | 507 | 45 | 7 | M48302 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 1.07e-03 | 142 | 45 | 4 | MM15431 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.16e-03 | 16 | 45 | 2 | MM17241 | |
| Pathway | BIOCARTA_P53_PATHWAY | 1.16e-03 | 16 | 45 | 2 | M14863 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 1.31e-03 | 17 | 45 | 2 | M48240 | |
| Pathway | REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION | 1.31e-03 | 17 | 45 | 2 | M45017 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 1.31e-03 | 17 | 45 | 2 | M39443 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 1.43e-03 | 70 | 45 | 3 | MM14824 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 1.44e-03 | 154 | 45 | 4 | M27697 | |
| Pubmed | 1.01e-06 | 12 | 59 | 3 | 35132438 | ||
| Pubmed | WBP2 PDE2A WASHC4 AKAP17A SMARCA4 KPNA6 ATM RAPGEF2 ARID1A CRTAP HSP90AB1 MICU1 | 1.38e-06 | 1285 | 59 | 12 | 35914814 | |
| Pubmed | Cell-autonomous requirement for TCF1 and LEF1 in the development of Natural Killer T cells. | 2.83e-06 | 2 | 59 | 2 | 26490636 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 16424171 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 27044748 | ||
| Pubmed | Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis. | 2.83e-06 | 2 | 59 | 2 | 8223271 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 34997313 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30918012 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 37741305 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 9462507 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 38169425 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 34615872 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 25083560 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 22111711 | ||
| Pubmed | Coffin-Siris syndrome in two chinese patients with novel pathogenic variants of ARID1A and SMARCA4. | 2.83e-06 | 2 | 59 | 2 | 35353340 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 36464671 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 18247340 | ||
| Pubmed | Beta-catenin/LEF1 activated enamelin expression in ameloblast-like cells. | 8.48e-06 | 3 | 59 | 2 | 20599763 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 1989880 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 38970714 | ||
| Pubmed | Differential expression of LEF1/TCFs family members in colonic carcinogenesis. | 8.48e-06 | 3 | 59 | 2 | 27433921 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 12731066 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 22875805 | ||
| Pubmed | Selectivity of chromatin-remodelling cofactors for ligand-activated transcription. | 8.48e-06 | 3 | 59 | 2 | 11780067 | |
| Pubmed | SWI/SNF inactivation in the endometrial epithelium leads to loss of epithelial integrity. | 8.48e-06 | 3 | 59 | 2 | 33075803 | |
| Pubmed | TCF1 and LEF1 Control Treg Competitive Survival and Tfr Development to Prevent Autoimmune Diseases. | 8.48e-06 | 3 | 59 | 2 | 31216480 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 10993919 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 27111144 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 8.48e-06 | 3 | 59 | 2 | 22426308 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 36252860 | ||
| Pubmed | Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity. | 8.48e-06 | 3 | 59 | 2 | 26862121 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 21900401 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 24413084 | ||
| Pubmed | 1.47e-05 | 28 | 59 | 3 | 30037996 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 38874786 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 31906887 | ||
| Pubmed | TCF transcription factors: molecular switches in carcinogenesis. | 1.69e-05 | 4 | 59 | 2 | 10528152 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 22621927 | ||
| Pubmed | LEF-1 negatively controls interleukin-4 expression through a proximal promoter regulatory element. | 1.69e-05 | 4 | 59 | 2 | 18579517 | |
| Pubmed | Pja2 Inhibits Wnt/β-catenin Signaling by Reducing the Level of TCF/LEF1. | 1.69e-05 | 4 | 59 | 2 | 30021253 | |
| Pubmed | The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers. | 1.69e-05 | 4 | 59 | 2 | 28262751 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 23103132 | ||
| Pubmed | Hsp90 interactions and acylation target the G protein Galpha 12 but not Galpha 13 to lipid rafts. | 1.69e-05 | 4 | 59 | 2 | 12117999 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 23504349 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 9806824 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 9395085 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 23572277 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 28863077 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 15863839 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 26214741 | ||
| Pubmed | Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. | 1.69e-05 | 4 | 59 | 2 | 30837262 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 37303493 | ||
| Pubmed | Mapping canonical Wnt signaling in the developing and adult retina. | 1.69e-05 | 4 | 59 | 2 | 17065530 | |
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 1.69e-05 | 4 | 59 | 2 | 15170388 | |
| Pubmed | Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. | 1.69e-05 | 4 | 59 | 2 | 11988099 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 30317028 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 17878164 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 33481850 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 12149400 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 9707615 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 25168959 | ||
| Pubmed | 1.87e-05 | 191 | 59 | 5 | 24146773 | ||
| Pubmed | Genetic associations of brain structural networks in schizophrenia: a preliminary study. | 2.02e-05 | 31 | 59 | 3 | 20691427 | |
| Pubmed | SCN11A DENND4A NOP14 GNA13 PKHD1 PALM APOB RAB1B ATM ARID1A HSP90AB1 | 2.68e-05 | 1442 | 59 | 11 | 35575683 | |
| Pubmed | Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2. | 2.82e-05 | 5 | 59 | 2 | 21285352 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 11447280 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 28844837 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 18086889 | ||
| Pubmed | p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes. | 2.82e-05 | 5 | 59 | 2 | 9584200 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 12200431 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 28202515 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 15929992 | ||
| Pubmed | Retroposition of autosomal mRNA yielded testis-specific gene family on human Y chromosome. | 2.82e-05 | 5 | 59 | 2 | 10192397 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 37074193 | ||
| Pubmed | Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. | 2.82e-05 | 5 | 59 | 2 | 17981117 | |
| Pubmed | 2.92e-05 | 35 | 59 | 3 | 32504627 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 2.99e-05 | 949 | 59 | 9 | 36574265 | |
| Pubmed | 3.83e-05 | 222 | 59 | 5 | 37071664 | ||
| Pubmed | Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. | 4.23e-05 | 6 | 59 | 2 | 8551560 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 16940996 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 7859280 | ||
| Pubmed | Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention. | 4.23e-05 | 6 | 59 | 2 | 8529100 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 29337183 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 9488439 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 23152144 | ||
| Pubmed | SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts. | 4.23e-05 | 6 | 59 | 2 | 20128911 | |
| Pubmed | Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. | 4.23e-05 | 6 | 59 | 2 | 9008157 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 16230384 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 4.23e-05 | 6 | 59 | 2 | 25081545 | |
| Pubmed | Thymine DNA glycosylase promotes transactivation of β-catenin/TCFs by cooperating with CBP. | 4.23e-05 | 6 | 59 | 2 | 24748645 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 2064827 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 15037073 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 8876228 | ||
| Pubmed | Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. | 4.23e-05 | 6 | 59 | 2 | 7745752 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 29604291 | ||
| Pubmed | γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia. | 4.23e-05 | 6 | 59 | 2 | 30991025 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 9548947 | ||
| Pubmed | Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion. | 4.23e-05 | 6 | 59 | 2 | 8659115 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 24836425 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 9557700 | ||
| GeneFamily | AT-rich interaction domain containing | 3.76e-04 | 15 | 35 | 2 | 418 | |
| GeneFamily | Armadillo repeat containing|Importins | 5.46e-04 | 18 | 35 | 2 | 596 | |
| GeneFamily | Apolipoproteins | 7.47e-04 | 21 | 35 | 2 | 405 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.06e-03 | 25 | 35 | 2 | 504 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.13e-03 | 43 | 35 | 2 | 409 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.23e-03 | 66 | 35 | 2 | 722 | |
| GeneFamily | EF-hand domain containing | 8.62e-03 | 219 | 35 | 3 | 863 | |
| Coexpression | GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN | 3.30e-06 | 184 | 58 | 6 | M6593 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP | 5.03e-06 | 198 | 58 | 6 | M5302 | |
| Coexpression | GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN | 2.81e-05 | 160 | 58 | 5 | M338 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-Progen-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.12e-07 | 196 | 58 | 6 | 768fce92bcf47734fa6c4a448f1266f34583fb41 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-Progen|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.19e-07 | 197 | 58 | 6 | 4c928a4dde295bf220bcb0b2f30ca4a106b0e511 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-06 | 161 | 58 | 5 | 8e787cc7f5e818cad1a6ed143a5fe310993e030b | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-06 | 161 | 58 | 5 | ca9233370490e27b9a1892669d6b82db2136180e | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.67e-06 | 168 | 58 | 5 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-06 | 169 | 58 | 5 | 3a18b4ad826e6ab9cbfd1d51a23a1b67c9a08596 | |
| ToppCell | URO-Lymphocyte-B-Plasmablast|URO / Disease, Lineage and Cell Type | 3.00e-06 | 172 | 58 | 5 | 48888ef50ac784b38aca81da68f8a94ce09c670d | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-T_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-06 | 175 | 58 | 5 | bf1ef77d5fed2135ac83a4f7e445ab59d1538696 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-06 | 175 | 58 | 5 | 84d91843b34504636d5af6bda9930031409a1627 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-06 | 175 | 58 | 5 | 2368aa8318ab83e0e0fd539a17264f9e1d755cf1 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-06 | 177 | 58 | 5 | d6b7d387e7485ff52ce27f51df8b8050f49fd941 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 180 | 58 | 5 | 8cef63866c205df3825df84ce51fa61aa04ae491 | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-06 | 181 | 58 | 5 | 6bb4b19f7804319dd7cfa450c7d1c7b4e90f2450 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-06 | 181 | 58 | 5 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 183 | 58 | 5 | 86c67f258fa25a818797df5d4df7f27b44cb5381 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 184 | 58 | 5 | 3d7dd193a0826cc7a4e454a29236a16c315e5965 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 184 | 58 | 5 | 45577ff91c3b2b303acd97239dde2463ea7a429c | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-Progen-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.28e-06 | 185 | 58 | 5 | a139e95d31af9866ed2d4618ad67557851b98ef3 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 186 | 58 | 5 | 75258d88e23112fd1f0f7c71ef0366abb400d33e | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.62e-06 | 188 | 58 | 5 | 88b808561ebde997ac8a8bbd1d9bbda49bbb6646 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-06 | 191 | 58 | 5 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-06 | 191 | 58 | 5 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-06 | 193 | 58 | 5 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-06 | 193 | 58 | 5 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.25e-06 | 193 | 58 | 5 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.66e-06 | 196 | 58 | 5 | a6fcd4f9a39f8e4ff3076735dd615311104dfd1d | |
| ToppCell | normal-na-Hematopoietic|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.66e-06 | 196 | 58 | 5 | c2c1c894706428bad5bfc81e9ae0f921ab1286d3 | |
| ToppCell | normal-na-Hematopoietic-Progen-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.81e-06 | 197 | 58 | 5 | 8c4bda1842ff8bd808517c2aa179ac7596d1923d | |
| ToppCell | normal-na-Hematopoietic-Progen|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.81e-06 | 197 | 58 | 5 | 14de3db0b36412e801472a6c1502686ae7be9faa | |
| ToppCell | lymphoid|World / Lineage, cell class and subclass | 6.10e-06 | 199 | 58 | 5 | bf599721e7109cf9f361e9381544c291920c28be | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.10e-06 | 199 | 58 | 5 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | Sepsis-URO-Lymphocyte-B-Plasmablast|URO / Disease, condition lineage and cell class | 6.10e-06 | 199 | 58 | 5 | 0df6cafb7f3b607cbe80b6f25b4fd62d421d01ee | |
| ToppCell | (1)_T_cell-(16)_Tfh|(1)_T_cell / shred on Cell_type and subtype | 6.25e-06 | 200 | 58 | 5 | 3b28137e8e69b98fde9f6ab8320cb4d1c3543ef9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-05 | 154 | 58 | 4 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 157 | 58 | 4 | b337937a88f62030114a28d70a63168417672767 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 159 | 58 | 4 | 776139481f2d3630461b4dabca606ebf6e6f034e | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 159 | 58 | 4 | bbb19e2f0b7cee70836fa96dc22f888cbc403d28 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 160 | 58 | 4 | 8590281165eab6514a9f6a022b900d4c222c1044 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.77e-05 | 161 | 58 | 4 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.77e-05 | 161 | 58 | 4 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 161 | 58 | 4 | 334f540dff3508d451e5e85e8e4e8f3b8d6b74e7 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.77e-05 | 161 | 58 | 4 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 161 | 58 | 4 | 81d44438e4be4e68a59247e62f02026301a8a0c5 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.91e-05 | 162 | 58 | 4 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-05 | 164 | 58 | 4 | 2c48c6e4eeee845f0563982d0bfa2a176ca5ef61 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-05 | 166 | 58 | 4 | 0a7992bc673fca546636563ec3fc17a4298ab6b1 | |
| ToppCell | facs-Heart-RV-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-05 | 166 | 58 | 4 | c0fd3f3f5c3412746da279b856af0d28b9b70c5d | |
| ToppCell | facs-Heart-RV-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-05 | 166 | 58 | 4 | 33c4876df43b4c1d100699bca47459918bd054d6 | |
| ToppCell | facs-Heart-RV-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-05 | 166 | 58 | 4 | ac9b9df57d65ccbbf9ae3add50c5663efcd30dcb | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.64e-05 | 167 | 58 | 4 | 38b1f052d663fa8f407c54bdd2060216f26feb0e | |
| ToppCell | facs-Heart-LA-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 168 | 58 | 4 | 16c3313c4186fa327d71215f8eebc31fc12ff1c0 | |
| ToppCell | facs-Heart-LA-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 168 | 58 | 4 | 24d1e0a05cda09ee3b80208d75cb2b601023f3bf | |
| ToppCell | facs-BAT-Fat-24m-Lymphocytic-T_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 168 | 58 | 4 | e268e9ee43a2cbf6153bcdf1e6e7674090ee2e6c | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 168 | 58 | 4 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 168 | 58 | 4 | 68ef5d1043fca804032669bf990edf110d65cf63 | |
| ToppCell | facs-Heart-LA-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 168 | 58 | 4 | b952af95a68888adedd03b1b60836d18524611ab | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.96e-05 | 169 | 58 | 4 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.96e-05 | 169 | 58 | 4 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 71e5e27c3c4e6cc8dc9b063bd51c21c049f54416 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 255bbbd00d0e17510c5a8c5faa43ed90d887a9de | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.12e-05 | 170 | 58 | 4 | 282afbbea5c88d973cf44727c473a3615f0f02a3 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.12e-05 | 170 | 58 | 4 | f9596088a1a7686467e54eabaad5269f2c5fbfec | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.12e-05 | 170 | 58 | 4 | 9a18756e6721980d4b6c37bb52ddfe93ca79c5ab | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 7040f7b1e4d8d26db787449e557371c5d872c95a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.12e-05 | 170 | 58 | 4 | 65c7ed586e7615203a59999549892ed466a89502 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.12e-05 | 170 | 58 | 4 | 8e9b5f7bfb61f8d84d0b17fb0c191da4dabad63d | |
| ToppCell | Myeloid-Myeloid-D_(Mast_cell)|Myeloid / shred on cell class and cell subclass (v4) | 7.28e-05 | 171 | 58 | 4 | 5f1aafc4c55a9c6c3153430186a8a351425a3cb9 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.28e-05 | 171 | 58 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 7.28e-05 | 171 | 58 | 4 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | a9f0ccaca0d83bfec79e3251e346a165c34c242b | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 7.45e-05 | 172 | 58 | 4 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | f320813177f246926bfd5862b4e0f9bd828cebab | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | b3c12a4bb08ce931de6fe800b605f3e43adea0b5 | |
| ToppCell | normal-na-Hematopoietic-Progen-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.62e-05 | 173 | 58 | 4 | e666364eb110c1c976e5b09a632dd1454513f131 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 7456a417c5c1d4ba25f9489065aae322421308a6 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 35586a9e5f15b41609b6224e33eb3aa3cb7e03b7 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | cd635751f999e12b14c0accfa1c4c1fd3c1d4540 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 174 | 58 | 4 | 986e591d3d46009e53548dfa1f2126cf31063ef4 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 174 | 58 | 4 | 785be49a2dbbb1dff0fbced1b48b942c2f4a508d | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.79e-05 | 174 | 58 | 4 | 7c8cc5c2872fc7bcca7ebddaf5a6f20e617a2674 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 175 | 58 | 4 | b66731573e79576fbf17538059cb8243dd4903c4 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 175 | 58 | 4 | 392123b037ff48c924ebd020ac86891116a2dcd3 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 175 | 58 | 4 | 5f18077e5c3edc6a2708315db53683afa4a6d4a8 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 175 | 58 | 4 | a72c6ceca5ddbd34f652e7302defefa2d105e17e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 175 | 58 | 4 | 9a462e9e6f7bbb64abb09ad6c080df3576073540 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 175 | 58 | 4 | ca2eabf03b70353e7eb15b6f622b2f9223a99e18 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.96e-05 | 175 | 58 | 4 | f949613ee45f5d950578c512d197716855118d18 | |
| ToppCell | facs-Trachea-nan-18m-Lymphocytic-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 176 | 58 | 4 | 14c6c3fdb53f9dfc02b951bc955b90213110c089 | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 8.14e-05 | 176 | 58 | 4 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | facs-Trachea-nan-18m-Lymphocytic|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 176 | 58 | 4 | 9dd862dcee6947a53189728f6b4cd40e7b67cb71 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 176 | 58 | 4 | 2e3f25a338842384517656d05776a52cbfc62b52 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 176 | 58 | 4 | 0823088bc6b19c7ad784d83c2ccdfae80611afab | |
| ToppCell | facs-Trachea-nan-18m-Lymphocytic-T_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 176 | 58 | 4 | d990e7af8120210100d13caa0465b27cf77a451a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.32e-05 | 177 | 58 | 4 | 64b8f665fdaf975558af2ad7d9b54d206de8350c | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.32e-05 | 177 | 58 | 4 | 1921226196b2ab7919d9f843e60d9f4bd9ec9c57 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 177 | 58 | 4 | dba8b30a311051c22ca5f77697f5dbf9423c3ba0 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 8.32e-05 | 177 | 58 | 4 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-mature_NK_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 177 | 58 | 4 | 93379bfd7484812bb45aa27c0324a75be9641685 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 177 | 58 | 4 | 6561794ae3b14b5279b249eb5e93b80ef15ed82c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.32e-05 | 177 | 58 | 4 | db6de487ef7976b444afadbf3ac60b3259925566 | |
| Drug | Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 8.81e-06 | 190 | 58 | 6 | 4421_DN | |
| Drug | Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.08e-05 | 197 | 58 | 6 | 6819_DN | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | 1.15e-05 | 199 | 58 | 6 | 4571_UP | |
| Disease | Burkitt Leukemia | 2.90e-06 | 15 | 56 | 3 | C4721444 | |
| Disease | African Burkitt's lymphoma | 2.90e-06 | 15 | 56 | 3 | C0343640 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 6.14e-06 | 19 | 56 | 3 | DOID:4928 (is_marker_for) | |
| Disease | cancer (implicated_via_orthology) | 1.18e-05 | 268 | 56 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 3.52e-05 | 5 | 56 | 2 | C3281201 | |
| Disease | Burkitt Lymphoma | 4.42e-05 | 36 | 56 | 3 | C0006413 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 9.83e-05 | 8 | 56 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | multiple sclerosis | 1.28e-04 | 594 | 56 | 7 | MONDO_0005301 | |
| Disease | triglycerides to total lipids in large HDL percentage | 2.05e-04 | 60 | 56 | 3 | EFO_0022330 | |
| Disease | prostate cancer (is_marker_for) | 2.23e-04 | 156 | 56 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Coffin-Siris syndrome | 2.72e-04 | 13 | 56 | 2 | C0265338 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.75e-04 | 303 | 56 | 5 | EFO_0004612, EFO_0020945 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 3.17e-04 | 14 | 56 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 4.17e-04 | 16 | 56 | 2 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 4.17e-04 | 16 | 56 | 2 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 4.17e-04 | 16 | 56 | 2 | cv:C1839071 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 5.31e-04 | 18 | 56 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 5.93e-04 | 19 | 56 | 2 | C1333991 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 5.93e-04 | 19 | 56 | 2 | EFO_0802076 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 5.93e-04 | 19 | 56 | 2 | C2936783 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 7.26e-04 | 21 | 56 | 2 | EFO_0022246 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 7.48e-04 | 215 | 56 | 4 | EFO_0008317, EFO_0008591 | |
| Disease | Granulomatous Slack Skin | 7.98e-04 | 22 | 56 | 2 | C0376407 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 8.15e-04 | 220 | 56 | 4 | EFO_0004529, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 8.72e-04 | 224 | 56 | 4 | EFO_0004574, EFO_0008317 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 8.72e-04 | 23 | 56 | 2 | C0079773 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 8.86e-04 | 225 | 56 | 4 | EFO_0008317, EFO_0010351 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 8.93e-04 | 99 | 56 | 3 | EFO_0004611, EFO_0007878 | |
| Disease | Malignant neoplasm of breast | 9.04e-04 | 1074 | 56 | 8 | C0006142 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 9.46e-04 | 229 | 56 | 4 | EFO_0004639, EFO_0008317 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 9.73e-04 | 102 | 56 | 3 | EFO_0004329, EFO_0004611 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.00e-03 | 103 | 56 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | familial hyperlipidemia | 1.09e-03 | 106 | 56 | 3 | MONDO_0001336 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 1.12e-03 | 26 | 56 | 2 | OBA_2045194 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 1.12e-03 | 26 | 56 | 2 | OBA_2045191 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 1.12e-03 | 26 | 56 | 2 | C0009405 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 1.20e-03 | 27 | 56 | 2 | C1112155 | |
| Disease | Sezary Syndrome | 1.20e-03 | 27 | 56 | 2 | C0036920 | |
| Disease | cholesterol to total lipids in small LDL percentage | 1.20e-03 | 27 | 56 | 2 | EFO_0022241 | |
| Disease | cholesterol to total lipids in medium LDL percentage | 1.20e-03 | 27 | 56 | 2 | EFO_0022238 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 1.30e-03 | 28 | 56 | 2 | DOID:8634 (is_marker_for) | |
| Disease | antihyperlipidemic drug use measurement | 1.38e-03 | 115 | 56 | 3 | EFO_0803367 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 1.39e-03 | 29 | 56 | 2 | C1333990 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.51e-03 | 260 | 56 | 4 | EFO_0008317 | |
| Disease | cardiovascular disease | 1.74e-03 | 457 | 56 | 5 | EFO_0000319 | |
| Disease | coronary artery disease | 1.78e-03 | 1194 | 56 | 8 | EFO_0001645 | |
| Disease | celiac disease | 1.79e-03 | 126 | 56 | 3 | EFO_0001060 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RMYLKHGSPVKMMES | 111 | Q6NSW5 | |
| RRMDQMMPGKTKADA | 186 | Q03989 | |
| TFPKMMGKASANEML | 431 | Q9Y6F8 | |
| ITFPKMMGKASANEM | 431 | Q9Y6F7 | |
| KRYMAPEMLDDTMNV | 366 | Q8NER5 | |
| YPVKRTTKMAGMMIA | 131 | P08172 | |
| GNTMYPGMKARMEKE | 496 | Q9H9F9 | |
| YSMLFSPTEKGESMM | 451 | Q96F81 | |
| MMLAIKEAASDMSPY | 146 | Q13367 | |
| RVAPAYAKMGEMMLA | 176 | P17342 | |
| MDAMASPGKDNYRMK | 1 | O15131 | |
| SMVKSIKMNDVYGPM | 1766 | Q7Z401 | |
| AFMTMAAEIKKRMGP | 161 | Q9H0U4 | |
| LRTVDGSPMMKAAMY | 156 | O75781 | |
| DKMQKRRPKTFGMDM | 36 | Q08116 | |
| KTNMEEMTEMQGGKY | 286 | Q9H8V3 | |
| KPLNAFMLYMKEMRA | 301 | Q9UJU2 | |
| NTSDMMGRMSYEPNK | 1216 | O14497 | |
| SRFPEDMMMLKKSAF | 616 | P19113 | |
| PDARGDKMSQDSMMK | 61 | P98082 | |
| MGETMPSITKDMDLY | 156 | Q02252 | |
| NMNGLMADPMKVYKD | 411 | Q9Y618 | |
| MADPMKVYKDRQVMN | 416 | Q9Y618 | |
| TMGYMMAKKHLEINP | 616 | P08238 | |
| METMASPGKDNYRMK | 1 | O60684 | |
| MVPSYMAMTTAAKRK | 816 | Q8NI77 | |
| KDLGNLMRTMGYMPT | 51 | Q9NP86 | |
| EKPKDMGFTRLMQAM | 446 | Q9BPX6 | |
| GNRPMEMMDREKAYI | 841 | O00408 | |
| KMMSFDTRAPMAAQG | 121 | Q14344 | |
| YNSNMSPEEKMMKRF | 91 | P78316 | |
| RSFMMEVKDPNMKGA | 196 | Q7Z6E9 | |
| MKMEKGEMYGNSPRF | 716 | Q9NY74 | |
| EMEKEETMSMYNPRK | 816 | Q16821 | |
| NGMMKRDGMKIPTYK | 2501 | Q13315 | |
| LKLSNDMMGSYAEMK | 1736 | P04114 | |
| PDDEMMKRNMAYYKS | 176 | O75718 | |
| FPEFLGMMARKMKDT | 66 | P27482 | |
| RMPGFSSKSEEMMRY | 46 | Q9NRM1 | |
| RMYLKHGSPVKMMES | 111 | Q8TCE6 | |
| PGQMEMLKLTMNKRY | 211 | Q9GZY0 | |
| KSGYMSDSDLMGKTM | 386 | Q8NEY1 | |
| KMSIEYKYEMMPNRT | 361 | O15226 | |
| DDPRYNQMKGMGMRS | 86 | P51532 | |
| YSMSEKMLGSRDMGA | 2171 | P08F94 | |
| MSALRGMKLMYKGED | 231 | Q02040 | |
| YQMAKSNSGFMAMVK | 246 | Q9BWW9 | |
| VSPTMDKEYMKGVMR | 201 | Q9Y4G8 | |
| MSYMRGKMQNSDCPK | 56 | Q5GAN3 | |
| YKESTYAKGKNMAMM | 306 | P0CB48 | |
| KGTRMDSSNYMPQMF | 606 | Q00722 | |
| KPLNAFMLYMKEMRA | 271 | P36402 | |
| SKYPQDLVMMEGKMM | 216 | P48023 | |
| YMSMQKPMTKTSVKA | 461 | Q2M389 | |
| NMKSPMVRKYAFHMI | 551 | Q9Y2L5 | |
| ISMMAESYNQPKAMK | 1381 | Q9UI33 | |
| RYMQKMGMTEDDKRN | 186 | P52735 | |
| PMLKESFEGMKMRST | 486 | Q8NBN3 | |
| QMKMYRGFTKMPHVQ | 66 | P35625 | |
| SKGKDAMQSFMMPFY | 61 | Q969T9 |